Logos Global Management LP Spring Works Therapeutics, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $3.98 Million - $5.72 Million	-110,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $2.53 Million - $5.34 Million	110,000 New	110,000 $4.62 Million
Q1 2020 May 15, 2020	SELL	$20.44 - $41.21 $2.75 Million - $5.54 Million	-134,397 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $2.38 Million - $5.31 Million	134,397 New	134,397 $5.17 Million

221

66.8M

64.7K

150K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.21B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.